Zixuan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zixuan Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Manqing Zhang
Jiujiang Clinical Precision Medicine Research Center Jiujiang China
1 shared publicationMoxin Wu
Jiujiang Clinical Precision Medicine Research Center Jiujiang China
1 shared publication- Tianrui Yu
Department of Neurology, School of Clinical Medicine Jiujiang University Jiujiang China
1 shared publication Xiaoping Yin
Department of Neurology, School of Clinical Medicine Jiujiang University Jiujiang China
1 shared publicationYanghang Chen
Department of Neurology, School of Clinical Medicine Jiujiang University Jiujiang China
1 shared publicationYuanyuan Xiang
Jiujiang Clinical Precision Medicine Research Center Jiujiang China
1 shared publication
Latest Publications
- Open Access
- 15 May 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (5) , e70422
Blood–Brain Barrier (BBB) Dysfunction in CNS Diseases: Paying Attention to Pericytes
Background: Dysfunction of the blood–brain barrier (BBB) is an important pathological mechanism in central nervous system (CNS) diseases and can trigger a series of pathological reactions, such as neuroinflammatory responses, oxidative stress, immune infiltration, etc., thereby worsening brain damage. However, pericytes are often overlooked by researchers, and no review research has yet summarized the mechanism by which pericytes contribute to BBB dysfunction in CNS diseases.Results: Therefore, this review explores the pathophysiology of BBB dysfunction in CNS diseases and provides a detailed account of the biological characteristics of pericytes, especially the controversy over their biomarkers. Subsequently, we review the role of pericytes in CNS diseases such as Alzheimer's disease, vascular dementia, multiple sclerosis, ischemic stroke, and hemorrhagic stroke, with a particular focus on the role of pericytes in BBB dysfunction. In addition, we also discuss treatments based on pericytes, such as regenerative medicine that induces pericyte differentiation and Pericyte‐Extracellular Vesicles.Conclusions: This review aims to provide a more comprehensive understanding and guidance on the role of pericytes in BBB dysfunction in CNS diseases and serve clinical treatment.
- 15 May 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (5) , e70422
Open AccessBlood–Brain Barrier (BBB) Dysfunction in CNS Diseases: Paying Attention to Pericytes
Background: Dysfunction of the blood–brain barrier (BBB) is an important pathological mechanism in central nervous system (CNS) diseases and can trigger a series of pathological reactions, such as neuroinflammatory responses, oxidative stress, immune infiltration, etc., thereby worsening brain damage. However, pericytes are often overlooked by researchers, and no review research has yet summarized the mechanism by which pericytes contribute to BBB dysfunction in CNS diseases.Results: Therefore, this review explores the pathophysiology of BBB dysfunction in CNS diseases and provides a detailed account of the biological characteristics of pericytes, especially the controversy over their biomarkers. Subsequently, we review the role of pericytes in CNS diseases such as Alzheimer's disease, vascular dementia, multiple sclerosis, ischemic stroke, and hemorrhagic stroke, with a particular focus on the role of pericytes in BBB dysfunction. In addition, we also discuss treatments based on pericytes, such as regenerative medicine that induces pericyte differentiation and Pericyte‐Extracellular Vesicles.Conclusions: This review aims to provide a more comprehensive understanding and guidance on the role of pericytes in BBB dysfunction in CNS diseases and serve clinical treatment.